|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600126953 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-21 21:56:20 |
|
注册时间: Date of Registration: |
2026-06-21 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
多病共存老年口腔患者诊疗风险探索及保障策略研究 |
|
Public title: |
Study on Exploration of Diagnostic and Treatment Risks and Safeguard Strategies for Elderly Dental Patients with Multimorbidity |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
多病共存老年口腔患者诊疗风险探索及保障策略研究 |
|
Scientific title: |
Study on Exploration of Diagnostic and Treatment Risks and Safeguard Strategies for Elderly Dental Patients with Multimorbidity |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刁艳君 |
研究负责人: |
刘显 |
|
Applicant: |
Yanjun Diao |
Study leader: |
Xian Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 28 8550 1452 |
研究负责人电话:
Study leader's |
+86 28 8550 2415 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
18109066740@163.com |
研究负责人电子邮件: Study leader's E-mail: |
jssyliuxian@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省成都市人民南路三段14号 |
研究负责人通讯地址: |
四川省成都市人民南路三段14号 |
|
Applicant address: |
14, Section 3, Renmin South Road, Wuhou District, Chengdu City, Sichuan Province |
Study leader's address: |
No.14, Section 3, Renmin South Road, Wuhou District, Chengdu, Sichuan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
四川大学华西口腔医院 |
||
|
Applicant's institution: |
West China Hospital of Stomatology, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西口腔医院 |
||
|
Affiliation of the Leader: |
West China Hospital of Stomatology, Sichuan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WCHSIRB-D-2025-537 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Research Ethics Committee West China Hospital of Stomatology Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-10-17 00:00:00 | ||
|
伦理委员会联系人: |
李灏来 |
||
|
Contact Name of the ethic committee: |
Li Haolai |
||
|
伦理委员会联系地址: |
四川省成都市人民南路三段14号 |
||
|
Contact Address of the ethic committee: |
No.14, Section 3, Renmin South Road, Wuhou District, Chengdu, Sichuan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8550 1479 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
hxkqllwyh@sina.com |
|
研究实施负责(组长)单位: |
四川大学华西口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital of Stomatology, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省成都市人民南路三段14号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.14, Section 3, Renmin South Road, Wuhou District, Chengdu, Sichuan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
四川省卫健委临床研究项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Clinical Research program of Health Commission of Sichuan Province |
||||||||||||||||||||||
|
研究疾病: |
不适用 |
||||||||||||||||||||||
|
Target disease: |
Not applicable |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
调查口腔医生对于诊疗风险的管理能力 探索多病共存老年口腔患者的诊疗风险 基于风险探索,构建全流程的诊疗风险保障策略 |
||||||||||||||||||||||
|
Objectives of Study: |
Investigation of Dental Practitioners’ Competence in Managing Treatment-Related Risks. Exploration of Treatment?Related Risks in Multimorbid Elderly Dental Patients. Development of a Full?Process Safeguard Strategy Based on Risk Exploration. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 从事口腔临床工作的医生或医学生,且自愿参与研究。 2. 患者: (1) 年龄>=65岁; (2) 经口腔医生诊断,存在需要接受口腔诊疗的情况,包括但不限于口腔内科治疗、口腔外科治疗、牙周治疗等; (3) 经病史询问及病历记录确认,患有经诊断的全身系统性疾病; (4) 患者或其法定监护人能够理解研究内容,并自愿签署书面知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Dentists or dental students engaged in clinical work, willing to voluntarily participate in the study. 2. Patients: (1) Aged 65 years or older; (2) Diagnosed by a dentist as requiring dental treatment, including but not limited to endodontic therapy, oral surgical procedures, and periodontal therapy; (3) Have a documented diagnosis of systemic disease(s) confirmed by medical history and medical records; (4) The patient or their legal guardian is able to understand the study content and voluntarily provides written informed consent. |
||||||||||||||||||||||
|
排除标准: |
1. 非口腔专业医生或医学生; 2. 问卷填写不完整或数据缺失严重者; 3. 认知与沟通障碍:存在严重的认知功能障碍(如中度至重度痴呆、意识障碍)或精神疾病,且无法通过监护人进行有效沟通与随访者; 4. 全身状况不稳定:美国麻醉医师协会(ASA)分级为IV级或V级(即患有未控制的、威胁生命的系统性疾病的患者);近期(3个月内)发生过急性心肌梗死、不稳定性心绞痛、脑血管意外等重大心血管事件者; 5. 患有晚期恶性肿瘤或其他疾病,预期生存期不足1年者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Individuals who are not dentists or dental students by training; 2. Those who complete the questionnaire incompletely or have significant missing data; 3. Cognitive or communication impairment: Presence of severe cognitive dysfunction (e.g., moderate to severe dementia, disturbance of consciousness) or psychiatric disorders that preclude effective communication or follow-up, even with the assistance of a legal guardian; 4. Unstable systemic condition: American Society of Anesthesiologists (ASA) physical status class IV or V (i.e., patients with uncontrolled, life-threatening systemic diseases). Additionally, patients who have experienced major cardiovascular events within the preceding 3 months, including acute myocardial infarction, unstable angina, or cerebrovascular accident; 5. Limited life expectancy: Patients with advanced malignant tumors or other diseases with an expected survival of less than one year. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-06-17 00:00:00至 To 2027-06-17 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-06-21 00:00:00 至 To 2027-06-17 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
知情同意书及随访文书记录统一专柜管理,电子数据专门电脑记录管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Informed consent forms and follow-up documentation shall be stored in a designated locked cabinet, while electronic data shall be managed through a dedicated computer system. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |